The global Peripheral Arterial Disease (PAD) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Peripheral Arterial Disease (PAD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peripheral Arterial Disease (PAD) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Peripheral Arterial Disease (PAD) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Peripheral Arterial Disease (PAD) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others

Segment by Application
Hospitals
Clinics
Others